Literature DB >> 27832227

Eosinophils in COPD: why should I care?

Frederico Leon Arrabal Fernandes1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27832227      PMCID： PMC5063436          DOI： 10.1590/S1806-37562016000400001

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  8 in total

1.  What is a disease?

Authors:  Jackie Leach Scully
Journal:  EMBO Rep       Date:  2004-07       Impact factor: 8.807

2.  Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials.

Authors:  Steven Pascoe; Nicholas Locantore; Mark T Dransfield; Neil C Barnes; Ian D Pavord
Journal:  Lancet Respir Med       Date:  2015-04-12       Impact factor: 30.700

3.  Induced sputum and peripheral blood cell profile in chronic obstructive pulmonary disease.

Authors:  Rogerio Rufino; Cláudia Henrique da Costa; Heitor Siffert Pereira de Souza; Kalil Madi; José Roberto Lape e Silva
Journal:  J Bras Pneumol       Date:  2007 Sep-Oct       Impact factor: 2.624

4.  Personalized respiratory medicine: exploring the horizon, addressing the issues. Summary of a BRN-AJRCCM workshop held in Barcelona on June 12, 2014.

Authors:  Alvar Agustí; Josep Maria Antó; Charles Auffray; Ferran Barbé; Esther Barreiro; Jordi Dorca; Joan Escarrabill; Rosa Faner; Laura I Furlong; Judith Garcia-Aymerich; Joaquim Gea; Bertil Lindmark; Eduard Monsó; Vicente Plaza; Milo A Puhan; Josep Roca; Juan Ruiz-Manzano; Laura Sampietro-Colom; Ferran Sanz; Luis Serrano; James Sharpe; Oriol Sibila; Edwin K Silverman; Peter J Sterk; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2015-02-15       Impact factor: 21.405

5.  Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.

Authors:  R Siva; R H Green; C E Brightling; M Shelley; B Hargadon; S McKenna; W Monteiro; M Berry; D Parker; A J Wardlaw; I D Pavord
Journal:  Eur Respir J       Date:  2007-02-14       Impact factor: 16.671

6.  Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial.

Authors:  C E Brightling; W Monteiro; R Ward; D Parker; M D Morgan; A J Wardlaw; I D Pavord
Journal:  Lancet       Date:  2000-10-28       Impact factor: 79.321

Review 7.  The asthma COPD overlap syndrome (ACOS).

Authors:  Stephen Bujarski; Amit D Parulekar; Amir Sharafkhaneh; Nicola A Hanania
Journal:  Curr Allergy Asthma Rep       Date:  2015-03       Impact factor: 4.806

8.  Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study.

Authors:  T M L Eagan; T Ueland; P D Wagner; J A Hardie; T E Mollnes; J K Damås; P Aukrust; P S Bakke
Journal:  Eur Respir J       Date:  2009-07-30       Impact factor: 16.671
  8 in total
  1 in total

1.  Peripheral Blood Eosinophils and Nine Years Mortality in COPD Patients.

Authors:  Robson Prudente; Renata Ferrari; Carolina B Mesquita; Luiz H S Machado; Estefânia A T Franco; Irma Godoy; Suzana E Tanni
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-04-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.